Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04417621
Title Study of Efficacy and Safety of LXH254 Combinations in Patients With Previously Treated Unresectable or Metastatic Melanoma
Recruitment Active, not recruiting
Phase Phase II
Variant Requirements Yes
Sponsors Novartis Pharmaceuticals
Age Groups: senior | child | adult
Covered Countries USA | ITA | FRA | DEU | BEL

Additional content available in CKB BOOST